SMTL ID : 9c55.1

Crystal structure of human PTPN2 in complex with active site inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.36 Å

Oligo State

monomer

Ligands

1 x 527: 5-(3-{[1-(BENZYLSULFONYL)PIPERIDIN-4-YL]AMINO}PHENYL)-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID

527.1: 18 residues within 4Å: Chain A: S.30, D.32, Y.49, D.51, Y.55, K.123, D.183, F.184, C.217, S.218, A.219, I.221, G.222, R.223, M.257, G.258, Q.261, Q.265 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:Y.49, A:D.51, A:I.221, A:M.257 Hydrogen bonds: A:F.184, A:S.218, A:R.223, A:R.223, A:Q.261, A:Q.265 Water bridges: A:K.123, A:A.219, A:G.222 Salt bridges: A:K.123, A:R.223

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bester, S.M. et al., Enhancing the apo protein tyrosine phosphatase non-receptor type 2 crystal soaking strategy through inhibitor-accessible binding sites. Acta Crystallogr.,Sect.F (2024)

Release Date

2024-09-04

Peptides

Tyrosine-protein phosphatase non-receptor type 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 2

Related Entries With Identical Sequence